SCHEMBL24326671

SCHEMBL24326671

Cc1cccc(C)c1-c1cc(O)nc(NSc2cccc(C(=O)N3CCCN(C(=O)C(C)(C)C)CC3)c2)n1

nearest known ligand 0.36

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.36
MAP3K7 O43318 1/20 0.36
SRC P12931 2/20 0.36
ITK Q08881 2/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HPGD P15428 1/20 0.35
NTRK1 P04629 2/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
PLA2G7 Q13093 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
MTOR P42345 1/20 0.33
SMG1 Q96Q15 1/20 0.33
EPHB4 P54760 1/20 0.33
NR1H2 P55055 1/20 0.33
NR1H3 Q13133 1/20 0.33
HPGDS O60760 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27024729 0.90 SRC (0.44) IRAK4MAP3K7SRCADORA2AHPGD
SCHEMBL27012810 0.89 AKR1C1 (0.41) IRAK4MAP3K7SRCITKADORA2A
SCHEMBL27012691 0.89 GRIN2B (0.36) IRAK4MAP3K7SRCITKSMN1; SMN2
SCHEMBL24326126 0.88 IRAK4 (0.34) IRAK4MAP3K7SRCITKADORA2A
SCHEMBL27012773 0.87 ATR (0.41) IRAK4MAP3K7SRCITKNTRK1
SCHEMBL27012787 0.85 SRC (0.41) SRCHPGDNTRK1
SCHEMBL24326644 0.85 PARP1 (0.38) IRAK4MAP3K7SRCMEN1KMT2A
SCHEMBL27012781 0.84 IRAK4 (0.35) IRAK4MAP3K7SRCITKADORA2A
SCHEMBL24325741 0.83 ACACB (0.40) SMN1; SMN2HPGDMEN1KMT2A
SCHEMBL27024732 0.83 MAP3K7 (0.34) IRAK4MAP3K7SRCITKSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076625-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed